Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

27277studies shown

Showing 7,225-7,236 of 27,277

CompletedNCT00246246

Long-acting risperidone injections or oral antipsychotics for bipolarity maintenance

About this title

A Randomized, Open-label Trial of Long-acting Injectable Risperidone Versus Oral Antipsychotic Medication in Patients With Bipolar Disorder

Read the official source — NCT00246246

Official study title

A Randomized, Open-label Trial of RISPERDAL® CONSTA™ Versus Oral Antipsychotic Care in Subjects With Bipolar Disorder

This study has finished and is no longer accepting participants.

Location not clearly listed

BipolarityMedication studyAges 18–65

Countries
Sponsor: Janssen-Ortho Inc., Canada

View study

CompletedNCT00723606

Intramuscular Ziprasidone for Schizophrenia

What is this study about?

Researchers compared Intramuscular ziprasidone mesylate and Intramuscular haloperidol, tracking side effects to assess safety and tolerability in people with schizophrenia.

This study has finished and is no longer accepting participants.

Multiple locations, including Baoding

SchizophreniaMedication studyAges 18–65

Countries: China
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

View study

CompletedEUCTR 2019-002992-33

A Randomized, Open-label, Rater-Blinded, Active-Controlled, International, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Flexibly Dosed Esketamine Nasal Spray Compared Wit...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Austria

DepressionHistorical research record

Countries: France, Belgium, Austria, + 11 others
Sponsor: Janssen-Cilag International NV

View study

CompletedEUCTR 2006-005585-40

A randomized, parallel group, multiple dose, 6 week study to evaluate safety, tolerability, and pharmacokinetics of asenapine in elderly subjects with psychosis.

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Czech Republic

Schizophrenia, BipolarityHistorical research record

Countries: Czechia
Sponsor: NV Organon

View study

CompletedNCT01354470

A study of Modafinil for Methamphetamine Dependence

Official study title

A Randomized, Placebo-Controlled Trial of Modafinil for Methamphetamine Dependence

This study has finished and is no longer accepting participants.

Multiple locations, including Lafayette

AddictionMedication studyAges 18–50

Countries: United States
Sponsor: California Pacific Medical Center Research Institute

View study

CompletedNCT01629537

A study of Stellate Ganglion Block in the Treatment of PTSD

Official study title

A Randomized, Placebo-Controlled Trial of Stellate Ganglion Block in the Treatment of Post Traumatic Stress Disorder

This study has finished and is no longer accepting participants.

In San Diego

PTSDPlacebo researchAges 18+

Countries: United States
Sponsor: United States Naval Medical Center, San Diego

View study

CompletedEUCTR 2006-006441-14

A randomized, rater-blinded cross-over multicenter study comparing the clinical efficacy of Ritalin® LA (methylphenidate) treatment (20 or 40 mg orally o.d.) in children with ADHD under different b...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Germany

ADHDHistorical research record

Countries: Germany
Sponsor: Novartis Pharma GmbH

View study

CompletedEUCTR 2017-000736-33

A randomized, subject and investigator blinded, placebo-controlled, parallel group study to investigate whether AFQ056 reduces cocaine use in patients diagnosed with Cocaine Use Disorder (CUD).

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Spain

AddictionHistorical research record

Countries: Spain
Sponsor: Novartis Farmacéutica S.A.

View study

CompletedNCT04655287

A Register Study of Effects Following Local Variation in Rates of Involuntary Care

Official study title

Do Low Rates of Coercion in Catchment Areas Predict Negative Effects for Persons With Severe Mental Disorders? A Register Study From Norway 2015-2017. Part of Reducing Coercion in Norway (ReCoN)

This study has finished and is no longer accepting participants.

Location not clearly listed

Schizophrenia, BipolarityObservational studyAges 18–65

Countries
Sponsor: University Hospital, Akershus

View study

CompletedNCT00283517

Treatment and medication adherence in a schizophrenia registry

About this title

A Registry of Treatment Adherence for Patients With Schizophrenia

Read the official source — NCT00283517

Official study title

Electronic Schizophrenia Treatment Adherence Registry, eSTAR

This study has finished and is no longer accepting participants.

Location not clearly listed

SchizophreniaObservational studyAges 18+

Countries
Sponsor: Janssen-Cilag, S.A.

View study

CompletedNCT00627341

A Relapse Prevention Program for Reducing Relapse and Fear of Food in People With Eating disorders

Official study title

Addressing Fear of Food in Anorexia Nervosa

This study has finished and is no longer accepting participants.

In New York

Eating disordersBehavioural studyAges 16–45

Countries: United States
Sponsor: New York State Psychiatric Institute

View study

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.